Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy

Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of Retinopathy

Background: Diabetic retinopathy (DR) is a leading cause of end-stage blindness globally and is arguably one of the most disabling complications of both Type 1 and Type 2 diabetes. Sodium Glucose Cotransporter-2 (SGLT2) inhibitors have now been successfully introduced to clinical medicine and exert...

Full description

Bibliographic Details
Main Authors: Lakshini Y. Herat, Jennifer R. Matthews, Elizabeth P. Rakoczy, Markus P. Schlaich, Vance B. Matthews
Format: Article
Language:English
Published: IMR Press 2023-04-01
Series:Frontiers in Bioscience-Landmark
Subjects:
diabetic retinopathy
diabetes
akimba
kimba
mouse models
sodium glucose cotransporters
sglt2 inhibitors
empagliflozin
canagliflozin
retinal vasculature
Online Access:https://www.imrpress.com/journal/FBL/28/4/10.31083/j.fbl2804083

Internet

https://www.imrpress.com/journal/FBL/28/4/10.31083/j.fbl2804083

Similar Items